Injections are given subcutaneously (just under the skin), and injection sites should be rotated daily to prevent lipoatrophy or irritation
Shetty A, Kantarjian HM, Champlin RE, Borthakur G, Badar T, Garcia-Manero G, Andersson BS, Oran B, Ciurea SO, Konopleva M, Andreeff, M, Kornblau SM, Wierda WG, Pierce S, Ravandi F, Cortes JE
Among the Eli Lilly trials is one for orforglipron (LY3502970), a novel, oral non-peptide GLP-1 RA, which is the subject of four trials in the clinicaltrials.gov data
In clinical practice, healthcare professionals may consider prescribing ondansetron or other antiemetics to help manage these symptoms, especially if they are severe enough to affect treatment adherence or quality of life
How is Semaglutide different from other weight loss medications